GUIDED THERAPEUTICS INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2015 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Guided Therapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2015 to Q2 2024.
  • Guided Therapeutics Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 56K shares, a 9.84% increase year-over-year.
  • Guided Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 51.1K shares.
  • Guided Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 32.5M shares.
  • Guided Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 13.4M shares, a 124141% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 56K +5.02K +9.84% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 54.8K +5.45K +11.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 51.1K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 51.5K -34.8M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 51K -26.3M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 49.3K -20.6M -99.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2022 34.8M* Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 26.3M* +13.1M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 20.7M +7.51M +57% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q2 2021 13.3M +13.3M +111375% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 13.2M +13.1M +19973% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 10.8K +7.47K +226% Oct 1, 2020 Dec 31, 2020 10-K 2021-04-07
Q3 2020 60.3K +57K +1718% Jul 1, 2020 Sep 30, 2020 10-Q/A 2020-11-05
Q2 2020 11.9K +8.63K +263% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-20
Q1 2020 65.6K +62.4K +1920% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-08-18
Q4 2019 3.3K -61.9K -94.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-07
Q3 2019 3.32K +2.93K +742% Jul 1, 2019 Sep 30, 2019 10-Q/A 2020-11-05
Q2 2019 3.28K +568 +20.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-20
Q1 2019 3.25K +755 +30.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-07-07
Q4 2018 65.2K +65.2K Oct 1, 2018 Dec 31, 2018 10-K 2020-04-20
Q3 2018 394 -6.49K -94.3% Jul 1, 2018 Sep 30, 2018 10-Q 2020-03-09
Q2 2018 2.72K +800 +41.8% Apr 1, 2018 Jun 30, 2018 10-Q 2020-02-11
Q1 2018 2.49K +1.55K +164% Jan 1, 2018 Mar 31, 2018 10-Q 2019-07-11
Q4 2017 0 Oct 1, 2017 Dec 31, 2017 10-K 2019-05-08
Q3 2017 6.88K +6.6K +2333% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 1.92K -39.1K -95.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 946 -109K -99.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q3 2016 283 +281 Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 41K -66.3K -61.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-18
Q1 2016 110K +109K +11195% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-19
Q3 2015 2* Jul 1, 2015 Sep 30, 2015 10-Q 2016-12-05
Q2 2015 107K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-17
Q1 2015 973 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.